- Home
- ARMP vs SIEB Comparison
ARMP vs SIEB Comparison
Compare ARMP & SIEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- SIEB
- Stock Information
- Founded
- ARMP N/A
- SIEB 1886
- Country
- ARMP United States
- SIEB United States
- Employees
- ARMP N/A
- SIEB N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- SIEB Investment Bankers/Brokers/Service
- Sector
- ARMP Health Care
- SIEB Finance
- Exchange
- ARMP Nasdaq
- SIEB Nasdaq
- Market Cap
- ARMP 92.4M
- SIEB 110.4M
- IPO Year
- ARMP N/A
- SIEB N/A
- Fundamental
- Price
- ARMP $2.86
- SIEB $3.06
- Analyst Decision
- ARMP Strong Buy
- SIEB
- Analyst Count
- ARMP 1
- SIEB 0
- Target Price
- ARMP $9.00
- SIEB N/A
- AVG Volume (30 Days)
- ARMP 12.1K
- SIEB 67.0K
- Earning Date
- ARMP 11-12-2025
- SIEB 11-11-2025
- Dividend Yield
- ARMP N/A
- SIEB N/A
- EPS Growth
- ARMP N/A
- SIEB N/A
- EPS
- ARMP N/A
- SIEB 0.24
- Revenue
- ARMP $6,868,000.00
- SIEB $86,037,000.00
- Revenue This Year
- ARMP $8.43
- SIEB N/A
- Revenue Next Year
- ARMP N/A
- SIEB N/A
- P/E Ratio
- ARMP N/A
- SIEB $12.39
- Revenue Growth
- ARMP 84.67
- SIEB 9.07
- 52 Week Low
- ARMP $0.90
- SIEB $1.92
- 52 Week High
- ARMP $3.14
- SIEB $5.77
- Technical
- Relative Strength Index (RSI)
- ARMP 57.54
- SIEB 50.29
- Support Level
- ARMP $2.79
- SIEB $2.48
- Resistance Level
- ARMP $3.03
- SIEB $2.63
- Average True Range (ATR)
- ARMP 0.16
- SIEB 0.18
- MACD
- ARMP 0.01
- SIEB 0.08
- Stochastic Oscillator
- ARMP 62.16
- SIEB 82.58
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About SIEB Siebert Financial Corp.
Siebert Financial Corp is a diversified financial services firm and provides a full range of brokerage and financial advisory services including securities brokerage, investment advisory and insurance offerings, and corporate stock plan administration solutions. The firm mainly provides online and traditional brokerage and related services to retail investors and also acts as an investment advisor for its subsidiary. The company operates in the securities brokerage and asset management industry. It also engages in Insurance services, Robo-advisory technology, and Prime brokerage business through its subsidiaries.